Larotrectinib Capsules and Pneumococcal Conjugate Vaccine (13-Valent)
Determining the interaction of Larotrectinib Capsules and Pneumococcal Conjugate Vaccine (13-Valent) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
Generic Name: pneumococcal 13-valent vaccine
Brand name: Prevnar 13
Synonyms: Pneumococcal 13-valent conjugate vaccine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Larotrectinib Capsules-Pneumococcal Conjugate Vaccine (7-Valent)
- Larotrectinib Capsules-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Larotrectinib Capsules-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Larotrectinib Capsules-Pneumovax 23
- Larotrectinib Capsules-PNV - Omega
- Larotrectinib Capsules-PNV Iron Polysaccharides, Folic Acid, DHA
- Pneumococcal Conjugate Vaccine (13-Valent)-Larotrectinib Oral Solution
- Pneumococcal Conjugate Vaccine (13-Valent)-Larotrectinib Sulfate
- Pneumococcal Conjugate Vaccine (13-Valent)-Lartruvo
- Pneumococcal Conjugate Vaccine (13-Valent)-Larynex
- Pneumococcal Conjugate Vaccine (13-Valent)-Laryng-O-Jet
- Pneumococcal Conjugate Vaccine (13-Valent)-Laryngesic